| PMBJX | RSDGX | PMBJX / RSDGX | |
| Total Expense Ratio | 0.78 | 1.40 | 56% |
| Annual Report Gross Expense Ratio | 0.78 | 1.53 | 51% |
| Fund Existence | 25 years | 29 years | - |
| Gain YTD | -0.564 | 2.642 | -21% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 30.8B | 81.9M | 37,607% |
| Annual Yield % from dividends | 0.06 | 0.00 | - |
| Returns for 1 year | -6.46 | 1.79 | -361% |
| Returns for 3 years | 32.39 | 6.34 | 511% |
| Returns for 5 years | 25.52 | -43.20 | -59% |
| Returns for 10 years | 89.12 | -52.36 | -170% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GDMN | 80.97 | 0.86 | +1.07% |
| WisdomTree Efcnt Gld Pls Gld Ms Stgy ETF | |||
| SIXP | 30.84 | 0.08 | +0.26% |
| AllianzIM US Lrg Cp 6M Bfr10 Mar/Sep ETF | |||
| ILTB | 50.15 | -0.07 | -0.14% |
| iShares Core 10+ Year USD Bond ETF | |||
| EFAA | 52.17 | -0.11 | -0.21% |
| Invesco MSCI EAFE Income Advantage ETF | |||
| IBB | 165.22 | -1.25 | -0.75% |
| iShares Biotechnology ETF | |||